Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference28 articles.
1. Clinical and molecular features of treatment-related neuroendocrine prostate cancer;Akamatsu;Int J Urol,2018
2. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study;Aggarwal;J Clin Oncol,2018
3. Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial;Flechon;Ann Oncol,2011
4. Neuroendocrine prostate cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis;Wang;J Clin Oncol,2014
5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer;Anticancer Research;2023-08-30
2. Treatment outcome after sequential chemotherapy with cisplatin-etoposide, amrubicin and nogitecan in patients with treatment-related pure small-cell neuroendocrine prostate cancer;Japanese Journal of Clinical Oncology;2023-02-24
3. Status epilepticus from GABABR antibody positive encephalitis due to de novo mixed small cell and adenocarcinoma of the prostate;BMJ Case Reports;2020-11
4. Amrubicin;Reactions Weekly;2020-09
5. The 2020 Bladder Cancer Discrepancy Issue;Clinical Genitourinary Cancer;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3